Skip to main content
Clinical Trials/NCT01274117
NCT01274117
Terminated
N/A

Randomized Trial Comparing Transposition of the Basilic Vein, for Vascular Access, Performed in One-stage Versus Two-stages

University of Patras1 site in 1 country16 target enrollmentDecember 2010

Overview

Phase
N/A
Intervention
Not specified
Conditions
Brachiobasilic Arteriovenous Fistula
Sponsor
University of Patras
Enrollment
16
Locations
1
Primary Endpoint
Long term primary, primary assisted and secondary patency
Status
Terminated
Last Updated
8 years ago

Overview

Brief Summary

Arteriovenous fistulas (AVFs) are made by joining a vein to an artery in order to get the vein dilated with sufficient blood flow in order to puncture the vein and clear the blood from wastes, in patients whose kidneys are destroyed and cannot provide this function. The success rate of this procedure varies between 50-80% and depends mainly on the size of the vein, with success being higher with larger veins. One of the veins used for an AVF is the basilic vein, located at the upper arm. This vein is however deeply located and necessitates movement (transposition) during surgery to a less deep and lateral path before it is joined to the artery, in order to be used. A single study has shown that surgery performed in two parts (one to enlarge the vein and the second one to relocate the enlarged vein under the wound, not in a new path) is more successful than doing the procedure altogether.

The aim of this study is to confirm the findings of the single study mentioned above (one versus two stages of basilic vein AVF), with the difference that the vein will be relocated outside the main wound, a method that is widely accepted as being better.

Detailed Description

Arteriovenous fistulas (AVFs) are made by anastomosing a vein to an artery in order to get the vein dilated with sufficient blood flow in order to puncture the vein and perform hemodialysis in patients with renal failure. The success rate of this procedure varies between 50-80% and depends mainly on the size of the vein, with success being higher with larger veins. One of the veins used for an AVF is the basilic vein, located at the upper arm. This vein is however deeply located and necessitates transposition during surgery to a less deep and lateral subcutaneous plane before the anastomosis with the artery, in order to be used. A single study has shown that surgery performed in two stages (one to enlarge the vein and the second one to relocate the enlarged vein under the wound, not in a new path) is more successful than doing the procedure in one stage. The aim of this study is to confirm the findings of the single study mentioned above (one versus two stages of basilic vein AVF), with the difference that the basilic vein will be relocated outside the main wound, a method that is widely accepted as being better.

Registry
clinicaltrials.gov
Start Date
December 2010
End Date
May 2014
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Stavros Kakkos

Assistant Professor

University of Patras

Eligibility Criteria

Inclusion Criteria

  • chronic renal failure on hemodialysis
  • chronic renal failure with anticipated hemodialysis

Exclusion Criteria

  • Patient unwillingness, not consenting
  • Cephalic vein options
  • Basilic vein less than 2.5 mm
  • Basilic vein with intrinsic lesions, unsuitable for use

Outcomes

Primary Outcomes

Long term primary, primary assisted and secondary patency

Time Frame: 1-3 years

Long term primary, primary assisted and secondary patency

Maturation rate

Time Frame: 6-10 weeks

Usage of the AVF (or clearance in case of pre-hemodialysis)

Secondary Outcomes

  • Complication rate(1-3 years)
  • Basilic vein size(4 weeks)

Study Sites (1)

Loading locations...

Similar Trials